282 related articles for article (PubMed ID: 19302919)
21. Targeting receptor tyrosine kinase signaling in acute myeloid leukemia.
Doepfner KT; Boller D; Arcaro A
Crit Rev Oncol Hematol; 2007 Sep; 63(3):215-30. PubMed ID: 17658267
[TBL] [Abstract][Full Text] [Related]
22. Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors.
Gyurkocza B; Plescia J; Raskett CM; Garlick DS; Lowry PA; Carter BZ; Andreeff M; Meli M; Colombo G; Altieri DC
J Natl Cancer Inst; 2006 Aug; 98(15):1068-77. PubMed ID: 16882944
[TBL] [Abstract][Full Text] [Related]
23. Single cell analysis of phosphoinositide 3-kinase/Akt and ERK activation in acute myeloid leukemia by flow cytometry.
Bardet V; Tamburini J; Ifrah N; Dreyfus F; Mayeux P; Bouscary D; Lacombe C
Haematologica; 2006 Jun; 91(6):757-64. PubMed ID: 16769577
[TBL] [Abstract][Full Text] [Related]
24. FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia.
Parcells BW; Ikeda AK; Simms-Waldrip T; Moore TB; Sakamoto KM
Stem Cells; 2006 May; 24(5):1174-84. PubMed ID: 16410383
[TBL] [Abstract][Full Text] [Related]
25. Integrin-linked kinase acts as a pro-survival factor against high glucose-associated osmotic stress in human mesangial cells.
Ohnishi M; Hasegawa G; Yamasaki M; Obayashi H; Fukui M; Nakajima T; Ichida Y; Ohse H; Mogami S; Yoshikawa T; Nakamura N
Nephrol Dial Transplant; 2006 Jul; 21(7):1786-93. PubMed ID: 16611685
[TBL] [Abstract][Full Text] [Related]
26. The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia.
Kasper S; Breitenbuecher F; Hoehn Y; Heidel F; Lipka DB; Markova B; Huber C; Kindler T; Fischer T
Leuk Res; 2008 Nov; 32(11):1698-708. PubMed ID: 18556063
[TBL] [Abstract][Full Text] [Related]
27. Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation.
Bugarski D; Krstic A; Mojsilovic S; Vlaski M; Petakov M; Jovcic G; Stojanovic N; Milenkovic P
Exp Biol Med (Maywood); 2007 Jan; 232(1):156-63. PubMed ID: 17202596
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of FLT3 phosphorylation status and its response to drugs by flow cytometry in AML blast cells.
Grafone T; Palmisano M; Nicci C; Martelli AM; Emanuela O; Storti S; Baccarani M; Martinelli G
Hematol Oncol; 2008 Sep; 26(3):159-66. PubMed ID: 18383555
[TBL] [Abstract][Full Text] [Related]
29. AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia.
Eriksson A; Kalushkova A; Jarvius M; Hilhorst R; Rickardson L; Kultima HG; de Wijn R; Hovestad L; Fryknäs M; Öberg F; Larsson R; Parrow V; Höglund M
Biochem Pharmacol; 2014 Jan; 87(2):284-91. PubMed ID: 24200998
[TBL] [Abstract][Full Text] [Related]
30. Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells.
Minke KS; Staib P; Puetter A; Gehrke I; Gandhirajan RK; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
Eur J Haematol; 2009 Mar; 82(3):165-75. PubMed ID: 19067737
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases.
Schmidt-Arras DE; Böhmer A; Markova B; Choudhary C; Serve H; Böhmer FD
Mol Cell Biol; 2005 May; 25(9):3690-703. PubMed ID: 15831474
[TBL] [Abstract][Full Text] [Related]
32. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.
Tabe Y; Jin L; Tsutsumi-Ishii Y; Xu Y; McQueen T; Priebe W; Mills GB; Ohsaka A; Nagaoka I; Andreeff M; Konopleva M
Cancer Res; 2007 Jan; 67(2):684-94. PubMed ID: 17234779
[TBL] [Abstract][Full Text] [Related]
33. Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts.
Illmer T; Thiede C; Fredersdorf A; Stadler S; Neubauer A; Ehninger G; Schaich M
Clin Cancer Res; 2005 May; 11(9):3217-24. PubMed ID: 15867216
[TBL] [Abstract][Full Text] [Related]
34. Integrin-linked kinase is dispensable for multiple myeloma cell survival.
Steinbrunn T; Siegmund D; Andrulis M; Grella E; Kortüm M; Einsele H; Wajant H; Bargou RC; Stühmer T
Leuk Res; 2012 Sep; 36(9):1165-71. PubMed ID: 22658851
[TBL] [Abstract][Full Text] [Related]
35. Regulation of FLT3 and its ligand in normal hematopoietic progenitor cells.
Weisel KC; Yildirim S; Schweikle E; Kanz L; Möhle R
Ann Hematol; 2009 Mar; 88(3):203-11. PubMed ID: 18797870
[TBL] [Abstract][Full Text] [Related]
36. New agents in the treatment of acute myeloid leukemia: a snapshot of signal transduction modulation.
Bao T; Smith BD; Karp JE
Clin Adv Hematol Oncol; 2005 Apr; 3(4):287-96, 302. PubMed ID: 16167001
[TBL] [Abstract][Full Text] [Related]
37. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
Koul D; Shen R; Bergh S; Lu Y; de Groot JF; Liu TJ; Mills GB; Yung WK
Mol Cancer Ther; 2005 Nov; 4(11):1681-8. PubMed ID: 16275989
[TBL] [Abstract][Full Text] [Related]
38. Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death.
Weidenaar AC; de Jonge HJ; Fidler V; ter Elst A; Meeuwsen-de Boer T; Douwes J; Bouma-ter Steege JC; Hählen K; Kamps WA; de Bont ES
Anticancer Drugs; 2008 Jan; 19(1):45-54. PubMed ID: 18043129
[TBL] [Abstract][Full Text] [Related]
39. T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death.
Chiu CF; Weng JR; Jadhav A; Wu CY; Sargeant AM; Bai LY
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537872
[TBL] [Abstract][Full Text] [Related]
40. Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.
Guo L; Yu W; Li X; Zhao G; Liang J; He P; Wang K; Zhou P; Jiang Y; Zhao M
Exp Eye Res; 2008 Dec; 87(6):551-60. PubMed ID: 18926819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]